GRANOCYTE - 34 million IU (Lenograstim rHuG-CSF) ( DrugBank: Lenograstim )


1 disease
IDDisease name (Link within this page)Number of trials
57Idiopathic dilated cardiomyopathy1

57. Idiopathic dilated cardiomyopathy


Clinical trials : 11 Drugs : 23 - (DrugBank : 12) / Drug target genes : 9 - Drug target pathways : 35
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2009-013112-12-GB
(EUCTR)
22/04/201017/03/2010Randomised Controlled Trial To Compare The effects of G-CSF(Granocyte™) And Autologous Bone Marrow Progenitor Cells On Quality Of Life And Left Ventricular Function In Patients with Idiopathic Dilated Cardiomyopathy - REGENERATE-DCMRandomised Controlled Trial To Compare The effects of G-CSF(Granocyte™) And Autologous Bone Marrow Progenitor Cells On Quality Of Life And Left Ventricular Function In Patients with Idiopathic Dilated Cardiomyopathy - REGENERATE-DCM Idiopathic Dilated Cardiomyopathy
Level: LLTClassification code 10056419Term: Dilated Cardiomyopathy
Trade Name: Granocyte Lenograstim
Product Name: GRANOCYTE - 34 million IU (Lenograstim rHuG-CSF)
Product Code: PL 12185/0002 & PL 12185/0005(WATER FOR INJECTION)
Barts & the London NHS TrustNULLNot RecruitingFemale: yes
Male: yes
United Kingdom